## **Core Concept**
Transplacental carcinogenesis refers to the process by which a carcinogen is transferred from mother to fetus through the placenta, potentially leading to cancer in the offspring. This concept is crucial in understanding the prenatal origins of certain cancers. The classical example of transplacental carcinogenesis involves diethylstilbestrol (DES), a synthetic estrogen.

## **Why the Correct Answer is Right**
The correct answer, **Diethylstilbestrol (DES)**, is a well-documented example of a substance causing transplacental carcinogenesis. DES was prescribed to pregnant women between about 1940 and 1971 to prevent miscarriage, premature labor, and related complications of pregnancy. It was later found that exposure to DES in the womb was associated with a rare form of vaginal cancer, known as clear cell adenocarcinoma, in daughters of these women. This cancer can occur in females exposed to DES prenatally, often many years after the exposure.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Not provided, but assuming it could be another chemical or drug, without specifics, it's hard to directly refute.
- **Option B:** Similarly, without specifics, any other option provided would need to be evaluated against known carcinogens and their mechanisms of action.
- **Option C:** If this option were another substance, it would need to be assessed for its potential to cause cancer through transplacental exposure.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Diethylstilbestrol (DES) exposure in utero** is associated not only with clear cell adenocarcinoma of the vagina but also with an increased risk of breast cancer in women exposed prenatally. This historical episode highlights the importance of careful use of medications during pregnancy and the potential long-term consequences for offspring.

## **Correct Answer:** . Diethylstilbestrol (DES)